This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Sat May 25, 2013 3:43 pm

View unanswered posts | View active topics


Board index » Treatments » Gilenya

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 
  Print view Previous topic | Next topic 
Author Message
squiffy2
PostPosted: Wed Mar 13, 2013 1:46 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1689
Novartis AG said it will present new data on Multiple Sclerosis or MS treatment at the 65th annual meeting of the American Academy of Neurology or AAN.

It will highlight growing clinical trial and real-world experience with Gilenya (fingolimod), the first once-daily oral therapy approved to treat people with relapsing MS or RMS. Updates on studies of Gilenya in people with primary-progressive MS or PPMS and the investigational agent BAF312 (siponimod) in people with secondary-progressive MS or SPMS will also be communicated, the company said... Read More - http://www.ms-uk.org/index.cfm/gilenya

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 

Board index » Treatments » Gilenya

All times are UTC - 8 hours [ DST ]

Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Oman licenses world's first oral drug for Multiple Sclerosis

squiffy2

0

835

Mon Jul 25, 2011 7:32 am

squiffy2 View the latest post

There are no new unread posts for this topic. Gilenya reduces brain loss in Multiple Sclerosis patients

squiffy2

0

721

Mon Oct 15, 2012 12:13 pm

squiffy2 View the latest post

There are no new unread posts for this topic. EU to rule on safety of Novartis's Gilenya MS pill

squiffy2

0

748

Wed Apr 18, 2012 4:21 am

squiffy2 View the latest post

There are no new unread posts for this topic. Novartis investigating death possibly linked to Gilenya

squiffy2

0

1146

Tue Dec 13, 2011 12:27 am

squiffy2 View the latest post

There are no new unread posts for this topic. Japan approves Novartis’ oral MS drug Gilenya

squiffy2

0

725

Wed Sep 28, 2011 1:09 am

squiffy2 View the latest post

 


Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: